Загрузка...
Evaluating the safety of a rotavirus vaccine: the REST of the story
The Rotavirus Efficacy and Safety Trial (REST) was a blinded, placebo-controlled study of the live pentavalent human-bovine vaccine, RotaTeq® (Merck & Co. Inc., West Point, PA). REST was noteworthy because its primary objective was to evaluate the safety of RotaTeq® with regard to intussusceptio...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Sage
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2602609/ https://ncbi.nlm.nih.gov/pubmed/18375651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774508090507 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|